4.3 Letter

Safety of Apixaban Administered via Nasogastric Tube

Journal

CARDIOLOGY
Volume 142, Issue 1, Pages 39-39

Publisher

KARGER
DOI: 10.1159/000495577

Keywords

-

Funding

  1. Bristol-Myers Squibb
  2. Pfizer

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available